MEDICLIN Aktiengesellschaft announced consolidated earnings results for 2017. For the year, group sales could be raised by EUR 28.7 million or 5.0 % up to EUR 609.1 million compared to the previous year. By that, consolidated sales were clearly above the EUR 600 million mark at the first time. The Group-EBIT, adjusted for the one-off provision at the end of the year, improved from EUR 24.0 million to EUR 26.7 million. Adjusted total consolidated result was EUR 20.9 million. Without adjustment the Group-EBIT amounts to EUR 6.6 million compared to EUR 24.0 million a year ago and the total consolidated result attributable to shareholders of company to EUR 3.9 million compared to EUR 16.6 million a year ago. The earnings per share account to EUR 0.08 compared to EUR 0.35 a year ago. Net financial debt amounts to EUR 20.6 million. In the 2017 financial year EUR 46.8 million were invested in non-current assets (gross amount), including subsidies in the amount of EUR 7.2 million.

For the year 2018, the Management Board forecasts sales growth of 5.0% to 6.0% and a Group EBIT in the range of EUR 26 million to EUR 28 million slightly above previous year's level.